+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Bladder Cancer Drugs Market Research Reports

Japan Non-muscle Invasive Bladder Cancer - Market Insights, Epidemiology, and Market Forecast - 2032 - Product Thumbnail Image

Japan Non-muscle Invasive Bladder Cancer - Market Insights, Epidemiology, and Market Forecast - 2032

  • Report
  • January 2024
  • 146 Pages
  • Japan
From
Bladder cancer - Epidemiology Forecast to 2032 - Product Thumbnail Image

Bladder cancer - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Muscle Invasive Bladder cancer - Epidemiology Forecast to 2032 - Product Thumbnail Image

Muscle Invasive Bladder cancer - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Doxorubicin Market Report and Forecast 2023-2031 - Product Thumbnail Image

Doxorubicin Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 140 Pages
  • Global
From
Cyclophosphamide Drug Market Report and Forecast 2023-2031 - Product Thumbnail Image

Cyclophosphamide Drug Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Bladder Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Bladder Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • January 2023
  • 97 Pages
  • Global
From
Bladder Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Bladder Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • November 2022
  • 1018 Pages
  • Global
From
US Bladder Cancer Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Bladder Cancer Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
Global Bladder Cancer Clinical Trial Pipeline Highlights - 2022 - Product Thumbnail Image

Global Bladder Cancer Clinical Trial Pipeline Highlights - 2022

  • Report
  • August 2022
  • Global
From
Mitomycin C Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Mitomycin C Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • April 2023
  • 103 Pages
  • Global
From
Bladder Cancer Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Bladder Cancer Treatment Market Report and Forecast 2023-2031

  • Report
  • March 2023
  • 147 Pages
  • Global
From
Bladder Cancer Treatment Drugs Companies in China - Product Thumbnail Image

Bladder Cancer Treatment Drugs Companies in China

  • Report
  • July 2024
  • 66 Pages
  • China
From
Bladder Cancer Treatment Drugs Markets in China - Product Thumbnail Image

Bladder Cancer Treatment Drugs Markets in China

  • Report
  • July 2024
  • 235 Pages
  • China
From
Cyclophosphamide Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Cyclophosphamide Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • February 2024
  • 89 Pages
  • Global
From
Pegylated Liposomal Doxorubicin (PLD) Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type - Product Thumbnail Image

Pegylated Liposomal Doxorubicin (PLD) Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

  • Report
  • February 2024
  • 95 Pages
  • Global
From
Methotrexate Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type - Product Thumbnail Image

Methotrexate Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

  • Report
  • February 2024
  • 93 Pages
  • Global
From
Bladder Cancer Treatment Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

Bladder Cancer Treatment Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • October 2023
  • 101 Pages
  • Global
From
Doxorubicin Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Product Type - Product Thumbnail Image

Doxorubicin Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Product Type

  • Report
  • September 2023
  • 115 Pages
  • Global
From
Liposomal Doxorubicin Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Liposomal Doxorubicin Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • August 2023
  • 77 Pages
  • Global
From
Methotrexate Sodium Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Methotrexate Sodium Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • September 2023
  • 89 Pages
  • Global
From
Loading Indicator

The Bladder Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat bladder cancer. Bladder cancer is a type of cancer that affects the urinary tract and is the sixth most common type of cancer in the United States. Common treatments for bladder cancer include chemotherapy, radiation therapy, and surgery. Drugs used to treat bladder cancer are typically classified as either targeted therapies or immunotherapies. Targeted therapies are designed to target specific molecules or pathways in the body that are involved in the growth and spread of cancer cells. Immunotherapies are designed to stimulate the body’s own immune system to fight cancer cells. Some of the major companies in the Bladder Cancer Drugs market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are involved in the development and sale of drugs used to treat bladder cancer. Show Less Read more